0.080
-0.01 (-5.88%)
| Previous Close | 0.085 |
| Open | 0.080 |
| Volume | 1,647,000 |
| Avg. Volume (3M) | 1,468,065 |
| Market Cap | 61,557,600 |
| Price / Sales | 0.760 |
| Price / Book | 0.360 |
| 52 Weeks Range |
| Profit Margin | -22.89% |
| Operating Margin (TTM) | -18.43% |
| Diluted EPS (TTM) | -0.030 |
| Quarterly Revenue Growth (YOY) | 32.80% |
| Total Debt/Equity (MRQ) | 11.91% |
| Current Ratio (MRQ) | 2.08 |
| Operating Cash Flow (TTM) | -10.37 M |
| Levered Free Cash Flow (TTM) | -71.29 M |
| Return on Assets (TTM) | -4.22% |
| Return on Equity (TTM) | -10.04% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (MY) | Bearish | Bearish |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | CAREPLS | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | 3.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 0.40 |
|
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 28.03% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MR LIM KWEE SHYAN | 0.085 | - | 587,800 | 49,963 |
| MADAM NG SHU SI | 0.085 | - | 293,900 | 24,982 |
| Aggregate Net Quantity | 881,700 | |||
| Aggregate Net Value ($) | 74,945 | |||
| Aggregate Avg. Buy ($) | 0.085 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MR LIM KWEE SHYAN | Director | 22 Sep 2025 | Acquired (+) | 293,900 | 0.085 | 24,982 |
| MADAM NG SHU SI | Substantial Shareholder | 22 Sep 2025 | Acquired (+) | 293,900 | 0.085 | 24,982 |
| MR LIM KWEE SHYAN | Substantial Shareholder | 22 Sep 2025 | Acquired (+) | 293,900 | 0.085 | 24,982 |
| Date | Type | Details |
|---|---|---|
| 24 Sep 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM NG SHU SI |
| 24 Sep 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR LIM KWEE SHYAN |
| 24 Sep 2025 | Announcement | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| 24 Sep 2025 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - MR LIM KWEE SHYAN |
| 08 Sep 2025 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - MR LIM KWEE SHYAN |
| 08 Sep 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM NG SHU SI |
| 08 Sep 2025 | Announcement | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| 08 Sep 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR LIM KWEE SHYAN |
| 27 Aug 2025 | Announcement | Quarterly rpt on consolidated results for the financial period ended 30/06/2025 |
| 5Y Average Dividend Yield | 1.20% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 30 Aug 2021 | 13 Aug 2021 | 15 Sep 2021 | 0.02 Cash |
| 27 May 2021 | 07 May 2021 | 16 Jun 2021 | 0.02 Cash |
| 05 Mar 2021 | 19 Feb 2021 | 24 Mar 2021 | 0.02 Cash |
| 08 Jul 2020 | 05 Jun 2020 | 23 Jul 2020 | 0.005 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2021 | 0.060 | 3 | 5.77 |
| 2020 | 0.005 | 1 | 0.24 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |